Investor Access  ·  Abzu Refinery  ·  Phoenix Rising Solventless Equipment

Abzu Refinery Is Seeking Strategic Partners for Its Market Activation Phase.

The investment opportunity is available to qualified individuals by access only. Complete the form below to request entry. All submissions are held in confidence.

The IP position

The architecture of Abzu Refinery is the subject of active intellectual property work — proprietary methodology, confidential disclosure controls.

What is protected is the method itself — not any single component. Abzu is one integrated system of controlled separation & collection dynamics, and its defensibility is the calibrated environment as a whole, not a part that could be copied or designed around.

That is a durable, defensible position — and how the Refinery achieves it is Abzu's own. The substance of the IP position opens to serious parties under NDA, not in public materials.

Read more: Defensible by Method →
Request Investor Access

All submissions are held in confidence. This page is not indexed by search engines. Abzu Refinery  ·  Phoenix Rising Solventless Equipment

Investor Portal  ·  Abzu Refinery

Thank you. The following materials are available for qualified review.

You are viewing the pre-commercial investor brief for Abzu Refinery, developed by Phoenix Rising Solventless Equipment. The numbers below are drawn from actual machine operation — not projections, not benchmarks. We'll follow up by email to arrange a conversation.

01
The Investment Overview Opportunity summary, market position, and strategic thesis
▶

Full investor deck access link will be provided in your follow-up email. A structured conversation with the founder is the recommended entry point — the deck is a supplement, not the pitch.

Abzu Refinery is the first purpose-built architectural replacement for conventional ice-water trichome extraction. The market has operated on a retrofit — craft equipment adapted to commercial production — for over two decades. That retrofit is the industry standard. Abzu Refinery is the replacement.

The documentation is from actual machine operation on the Refinery as built. The Refinery is complete and operational. The next stage is building the first commercial unit.

The opportunity is commercialisation capital — not R&D funding. The science is done. The prototype is real. The documentation is from actual operational runs. Capital is being sought to bring the first commercial unit to market — and the window before that deployment is the window to be positioned at the most advantageous terms.

02
Key Metrics at a Glance Documented from actual machine operation — extended data available on request
▶
10% Documented output — cured trim conservative yield · ~10–14% range
~60% Labour reduction vs conventional extraction 1 operator / 2 machines vs 2–3 per comparable output
~75% Water reduction per batch Structural — not process-dependent

Full yield range: Cured/dried trim ~10–14% (10% conservative). Whole-plant flower ~20–25% (20% conservative) — both dry-weight basis. The floor reflects suboptimal input. The ceiling requires cultivar selection and protocol consistency. The 10% cured-trim figure is the conservative reference number.

Extended data including run logs, input material specifications, and operator time studies are available on request under NDA. Contact the founder via the link in Section 04 to initiate that conversation.

03
Current Build Status Where the machine and company stand today
▶
Development Stage Refinery complete and operational — seeking capital to build first commercial unit
IP Status Proprietary architecture — method protected as confidential IP, not component
Capital Deployed Self-funded to date. Capital is now being sought for first commercial unit build and market activation.
Capital Sought Market activation capital — manufacturing, commercialisation, and market entry. The science and engineering are complete. The ask is to bring what exists to market.
Tier Architecture Five machine tiers — Abzu Spring (7 L, medical-first), Abzu Brook (30 L, craft), Abzu Stream (110 L, production), Abzu River (215 L, commercial), and Abzu Delta (300 L, industrial). A medical-grade configuration of the same machine serves the pharmaceutical pathway. Companion Cryo-Prep Mill (four tiers) is a second proprietary product.
Revenue Model Hardware sales across five tiers. Toll processing and licensing pathways for the Stream, River and Delta configurations. Extended data and financial projections available under NDA.
Geographic Focus Western Canada initial. European market is a strategic target for the medical/pharmaceutical pathway — clean-label, low-carbon production is a regulatory direction across key markets.
04
Next Steps How to move from here to a structured conversation
▶

Request a Conversation

The fastest path from this page to a meaningful exchange is a direct conversation with the founder. The machine, the numbers, the architecture, and the opportunity are best understood in dialogue — not documentation.

Request a Conversation  ▶
Additional materials — including technical documentation, full financial projections, run log data, and partnership structures — are available under NDA. Request via the conversation link above. All materials are provided after a brief qualifying conversation with the founder. There is no form for this. There is a phone call.
Not Washed. Refined.